Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1998-1999

Authors

  • David Dawson WHO Collaborating Centre in Tuberculosis Bacteriology, Queensland Health Pathology Services

DOI:

https://doi.org/10.33321/cdi.2001.25.44

Keywords:

Mycobacterium tuberculosis complex, laboratory network, TB, tuberculosis, drug resistance

Abstract

The Australian Mycobacterium Reference Laboratory Network collected and analysed laboratory data on new diagnoses of infection with Mycobacterium tuberculosis complex in 1998 and 1999. Totals of 700 and 760 cases were identified, representing annual reporting rates of 3.7 and 4.0 cases of laboratory confirmed tuberculosis (TB) per 100,000 population in the years 1998 and 1999 respectively. Australia's TB reporting rates have varied little in the past decade, ranging from 3.7 to 4.1 cases per 100,000 population. Reporting rates vary between States, reflecting differences in the distribution of persons in 'high-risk' categories for TB. The male:female ratio decreased to almost 1:1. The median age for males with culture-confirmed TB is in the 45-49 age group; for females, the median is in the 35-39 age group. Pulmonary disease was diagnosed in 63 per cent of cases whereas disease of lymph nodes accounted for 21 per cent of all cases. Children have the lowest rates of culture-confirmed TB; males in the older age groups have the highest rates. Microscopy was positive for 60 per cent of culture-positive sputa, and for approximately 45 per cent of bronchoscopy specimens. The frequency of multi-drug resistance (less than 1%) was slightly lower than in previous years. Commun Dis Intell 2001;25:261-265.

Downloads

Download data is not yet available.

References

Global tuberculosis control: WHO Report 2001. WHO/CDS/ TB/2001.275. Geneva: World Health Organization 2001.

Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999;282:677-686.

Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, et al. Global trends in resistance to anti-tuberculosis drugs. N Engl J Med 2001;344:1294-1303.

National TB Advisory Committee. Tuberculosis in Australia, 1998. Commun Dis Intell 2001;25:1-8.

Dawson D, Anargyros P, Blacklock Z, Chew W, Dagnia H, Gow B, et al. Tuberculosis in Australia: an analysis of cases identified in reference laboratories in 1986-88. Pathology 1991;23: 130-134.

Patel A, Streeton J. Tuberculosis in Australia and New Zealand into the 1990's. Australian Government Publishing Service, Canberra. 1990

Dawson D. Tuberculosis in Australia: Bacteriologically confirmed cases and drug resistance, 1997. Commun Dis Intell 1999;23:349-353.

Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24.

Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities. Morbid Mortal Weekly Rep 1994;43:1-132.

Ramaswamy S, Musser JM. Molecular genetic basis of anti-microbial agent drug resistance in Mycobacterium tuberculosis. Tuber Lung Dis 1998;79:3-29.

Abate G, Hoffner SE, Thomsen VO, Miorner H. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur J Clin Microbiol Infect Dis 2000;20:329-33.

Downloads

Published

30/11/01

How to Cite

Dawson, David. 2001. “Tuberculosis in Australia: Bacteriologically Confirmed Cases and Drug Resistance, 1998-1999”. Communicable Diseases Intelligence 25 (November):261-65. https://doi.org/10.33321/cdi.2001.25.44.

Issue

Section

Annual report

Categories